FLUOROURACIL

FLUOROURACIL was reported 78715 times

FLUOROURACIL is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 DUCTAL ADENOCARCINOMA OF PANCREAS 108 0.3899
1 COLORECTAL CANCER METASTATIC 594 0.2504
2 PORTAL VENOUS GAS 83 0.2287
3 OESOPHAGEAL FISTULA 70 0.2201
4 MUCOSAL TOXICITY 57 0.2103
5 NON-CIRRHOTIC PORTAL HYPERTENSION 77 0.2048
6 TUMOUR PERFORATION 64 0.2013
7 DIHYDROPYRIMIDINE DEHYDROGENASE DEFICIENCY 42 0.1972
8 RECTAL CANCER METASTATIC 52 0.1494
9 ARTERIOSPASM CORONARY 592 0.1474
10 SKIN TOXICITY 794 0.1404
11 GASTROINTESTINAL ANASTOMOTIC LEAK 52 0.1333
12 ACUTE PROMYELOCYTIC LEUKAEMIA 131 0.1274
13 ANASTOMOTIC COMPLICATION 43 0.1250
14 ANASTOMOTIC LEAK 85 0.1225
15 HEPATECTOMY 38 0.1214
16 NODULAR REGENERATIVE HYPERPLASIA 76 0.1184
17 DERMATITIS ACNEIFORM 705 0.1157
18 FOCAL NODULAR HYPERPLASIA 58 0.1115
19 BACTERIAL TRANSLOCATION 35 0.1104
20 RECTAL PERFORATION 56 0.1039
21 HYPERAMMONAEMIC ENCEPHALOPATHY 179 0.1029
22 RECTAL ADENOCARCINOMA 60 0.0992
23 CHOLINERGIC SYNDROME 61 0.0956
24 GASTROINTESTINAL TOXICITY 427 0.0888
25 DEVICE RELATED THROMBOSIS 87 0.0882
26 ADENOCARCINOMA OF COLON 161 0.0859
27 CARBOHYDRATE ANTIGEN 19-9 INCREASED 45 0.0851
28 TOXIC LEUKOENCEPHALOPATHY 60 0.0826
29 PARONYCHIA 362 0.0823
30 STEATOHEPATITIS 43 0.0802
31 ILEAL PERFORATION 53 0.0799
32 COLON CANCER METASTATIC 128 0.0794
33 NEUTROPENIC COLITIS 163 0.0787
34 MYOPERICARDITIS 60 0.0769
35 RADIATION SKIN INJURY 87 0.0750
36 INTRAVASCULAR HAEMOLYSIS 41 0.0732
37 MUCOSAL INFLAMMATION 1846 0.0704
38 METASTASES TO PERITONEUM 177 0.0700
39 PERIPHERAL SENSORY NEUROPATHY 403 0.0689
40 INTERLEUKIN LEVEL INCREASED 38 0.0688
41 PORTAL HYPERTENSION 210 0.0680
42 TUMOUR NECROSIS 71 0.0672
43 MYOCARDIAL INJURY 75 0.0667
44 GASTROINTESTINAL PERFORATION 275 0.0661
45 RECALL PHENOMENON 55 0.0658
46 CARCINOEMBRYONIC ANTIGEN INCREASED 123 0.0634
47 PNEUMATOSIS INTESTINALIS 178 0.0623
48 MALIGNANT ASCITES 47 0.0613
49 AORTITIS 42 0.0612
50 SUBCLAVIAN VEIN THROMBOSIS 68 0.0597
51 HYPERAMMONAEMIA 296 0.0591
52 AORTIC THROMBOSIS 68 0.0588
53 ENTEROCUTANEOUS FISTULA 51 0.0578
54 ADMINISTRATION SITE EXTRAVASATION 57 0.0571
55 CARDIOTOXICITY 508 0.0569
56 BILIARY TRACT INFECTION 35 0.0563
57 NEUTROPENIC SEPSIS 398 0.0557
58 GRANULOCYTE COUNT DECREASED 102 0.0550
59 NEUROTOXICITY 963 0.0549
60 POLYNEUROPATHY 658 0.0549
61 HAEMATOTOXICITY 517 0.0544
62 PERITONEAL DISORDER 35 0.0540
63 METASTASES TO LIVER 946 0.0538
64 PULMONARY ARTERY THROMBOSIS 41 0.0534
65 VENOOCCLUSIVE LIVER DISEASE 261 0.0528
66 REVERSIBLE POSTERIOR LEUKOENCEPHALOPATHY SYNDROME 41 0.0524
67 ENTEROVESICAL FISTULA 39 0.0514
68 METASTASES TO SKIN 53 0.0513
69 ENTERITIS 326 0.0509
70 SYSTEMIC SCLERODERMA 37 0.0508
71 PRINZMETAL ANGINA 50 0.0503
72 LYMPHANGIOSIS CARCINOMATOSA 52 0.0499
73 DUODENAL PERFORATION 49 0.0499
74 CATHETER RELATED COMPLICATION 56 0.0497
75 ADENOCARCINOMA GASTRIC 46 0.0495
76 CATHETER RELATED INFECTION 50 0.0494
77 METASTASES TO LUNG 558 0.0482
78 SYSTEMIC INFECTION 80 0.0482
79 OCULAR TOXICITY 53 0.0480
80 DIFFUSE ALVEOLAR DAMAGE 55 0.0478
81 OESOPHAGEAL PERFORATION 39 0.0468
82 PELVIC ABSCESS 53 0.0461
83 JUGULAR VEIN THROMBOSIS 82 0.0460
84 PERFORATION 37 0.0459
85 HYPOMAGNESAEMIA 639 0.0458
86 ADENOCARCINOMA 102 0.0455
87 THERAPY PARTIAL RESPONDER 707 0.0453
88 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 150 0.0452
89 METASTASES TO PLEURA 47 0.0448
90 FEBRILE NEUTROPENIA 2928 0.0441
91 NEUTROPENIC INFECTION 42 0.0439
92 LARYNGOSPASM 118 0.0438
93 VASOSPASM 40 0.0435
94 RECTAL TENESMUS 53 0.0425
95 LEUKOENCEPHALOPATHY 156 0.0418
96 GASTROINTESTINAL NECROSIS 122 0.0418
97 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 963 0.0413
98 SUBRETINAL FLUID 45 0.0412
99 VENA CAVA THROMBOSIS 68 0.0409
100 BONE MARROW TOXICITY 47 0.0397
101 GASTROINTESTINAL STOMA COMPLICATION 62 0.0394
102 NEUTROPENIA 5299 0.0389
103 EASTERN COOPERATIVE ONCOLOGY GROUP PERFORMANCE STATUS WORSENED 48 0.0385
104 MYELOSUPPRESSION 1387 0.0385
105 SUBILEUS 80 0.0384
106 LARGE INTESTINE PERFORATION 266 0.0383
107 ACUTE ABDOMEN 56 0.0381
108 METASTASES TO LYMPH NODES 254 0.0376
109 CHOLANGITIS 233 0.0375
110 NEUROPATHY PERIPHERAL 3555 0.0373
111 TROPONIN I INCREASED 62 0.0372
112 BONE MARROW DEPRESSION 36 0.0369
113 PERIPHERAL MOTOR NEUROPATHY 51 0.0364
114 SMALL INTESTINAL PERFORATION 66 0.0352
115 PANCREATIC CARCINOMA METASTATIC 100 0.0351
116 STREPTOCOCCAL BACTERAEMIA 38 0.0349
117 ENTEROCOLITIS 200 0.0346
118 CARDIAC VENTRICULAR THROMBOSIS 44 0.0341
119 INTESTINAL ISCHAEMIA 187 0.0339
120 LIVER ABSCESS 110 0.0339
121 STOMA SITE HAEMORRHAGE 52 0.0337
122 FEBRILE BONE MARROW APLASIA 143 0.0336
123 STRESS CARDIOMYOPATHY 194 0.0333
124 AZOTAEMIA 133 0.0333
125 XEROSIS 41 0.0331
126 LARGE INTESTINAL OBSTRUCTION 74 0.0331
127 HYPOALBUMINAEMIA 257 0.0330
128 LEUKOPENIA 1646 0.0329
129 IMMUNE-MEDIATED HEPATIC DISORDER 63 0.0323
130 GASTRIC PERFORATION 88 0.0323
131 THROMBOCYTOPENIC PURPURA 44 0.0322
132 ONYCHOLYSIS 50 0.0320
133 LEFT VENTRICULAR DYSFUNCTION 214 0.0319
134 TUMOUR HAEMORRHAGE 91 0.0319
135 RASH PUSTULAR 230 0.0316
136 OESOPHAGEAL VARICES HAEMORRHAGE 68 0.0313
137 PERIPHERAL SENSORIMOTOR NEUROPATHY 39 0.0310
138 ORAL INTAKE REDUCED 75 0.0310
139 BONE MARROW FAILURE 629 0.0309
140 TUMOUR LYSIS SYNDROME 271 0.0308
141 METASTASIS 219 0.0306
142 OESOPHAGEAL STENOSIS 86 0.0302
143 PORTAL VEIN THROMBOSIS 97 0.0300
144 EXTRAVASATION 123 0.0299
145 VARICES OESOPHAGEAL 90 0.0297
146 ACUTE CORONARY SYNDROME 246 0.0297
147 NEUTROPHIL COUNT DECREASED 1195 0.0293
148 GENE MUTATION 58 0.0293
149 CUTANEOUS LUPUS ERYTHEMATOSUS 56 0.0288
150 APLASIA 56 0.0286
151 IMMUNE-MEDIATED LUNG DISEASE 52 0.0285
152 NEOPLASM PROGRESSION 989 0.0284
153 EMBOLISM ARTERIAL 34 0.0283
154 RESPIRATORY ALKALOSIS 46 0.0283
155 RECTAL CANCER 86 0.0280
156 DISEASE PROGRESSION 3309 0.0279
157 IMMUNE-MEDIATED MYOCARDITIS 45 0.0278
158 PNEUMOPERITONEUM 51 0.0276
159 INTESTINAL PERFORATION 309 0.0275
160 CACHEXIA 141 0.0274
161 VENOUS THROMBOSIS 107 0.0272
162 THROMBOCYTOPENIA 3047 0.0272
163 ILEUS 336 0.0270
164 SUBACUTE CUTANEOUS LUPUS ERYTHEMATOSUS 48 0.0270
165 PROTEINURIA 513 0.0270
166 HYPERBILIRUBINAEMIA 279 0.0269
167 ADENOCARCINOMA PANCREAS 34 0.0265
168 SECOND PRIMARY MALIGNANCY 220 0.0264
169 HEPATIC LESION 112 0.0259
170 NEUTROPHIL COUNT ABNORMAL 73 0.0258
171 FEMALE GENITAL TRACT FISTULA 44 0.0257
172 PROCTITIS 72 0.0257
173 INFECTIOUS PLEURAL EFFUSION 39 0.0256
174 STOMATITIS 1543 0.0254
175 INTERSTITIAL LUNG DISEASE 1209 0.0249
176 VENTRICULAR HYPOKINESIA 80 0.0249
177 ESCHERICHIA BACTERAEMIA 58 0.0246
178 BLOOD CULTURE POSITIVE 72 0.0240
179 HYPOKALAEMIA 1107 0.0240
180 VENTRICULAR DYSFUNCTION 62 0.0239
181 NEOPLASM RECURRENCE 81 0.0239
182 ACUTE MYELOID LEUKAEMIA 371 0.0238
183 HAEMOLYTIC URAEMIC SYNDROME 55 0.0237
184 MALIGNANT PLEURAL EFFUSION 40 0.0237
185 DISSEMINATED INTRAVASCULAR COAGULATION 333 0.0236
186 NEUROPATHY 40 0.0235
187 OESOPHAGITIS 257 0.0235
188 LYMPHADENOPATHY MEDIASTINAL 45 0.0235
189 EMBOLISM 195 0.0235
190 WOUND DEHISCENCE 79 0.0234
191 NECROTISING FASCIITIS 80 0.0227
192 DYSENTERY 42 0.0225
193 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 215 0.0225
194 HYPOVOLAEMIC SHOCK 107 0.0223
195 IMMUNE THROMBOCYTOPENIA 102 0.0223
196 DYSAESTHESIA 68 0.0222
197 HICCUPS 182 0.0222
198 HYPERTRANSAMINASAEMIA 154 0.0221
199 ORGANISING PNEUMONIA 108 0.0218
200 MALIGNANT NEOPLASM PROGRESSION 2227 0.0217
201 ABDOMINAL ABSCESS 94 0.0212
202 CARDIOMYOPATHY 307 0.0208
203 ABDOMINAL INFECTION 53 0.0207
204 INCORRECT DRUG ADMINISTRATION RATE 88 0.0207
205 IMMUNE-MEDIATED ENTEROCOLITIS 76 0.0206
206 IMMUNE-MEDIATED HEPATITIS 42 0.0205
207 ELECTROCARDIOGRAM ST SEGMENT DEPRESSION 45 0.0205
208 ODYNOPHAGIA 122 0.0204
209 CONGESTIVE CARDIOMYOPATHY 85 0.0204
210 EJECTION FRACTION DECREASED 316 0.0203
211 ARTERIAL THROMBOSIS 39 0.0202
212 STRIDOR 59 0.0200
213 PROCTALGIA 128 0.0199
214 SMALL INTESTINAL OBSTRUCTION 244 0.0198
215 RADIATION PNEUMONITIS 42 0.0196
216 ASCITES 574 0.0195
217 METASTASES TO BONE 320 0.0195
218 EMBOLISM VENOUS 59 0.0194
219 ILEUS PARALYTIC 86 0.0192
220 BLOOD ALBUMIN DECREASED 152 0.0191
221 BREAST CANCER RECURRENT 59 0.0187
222 PULMONARY INFARCTION 44 0.0186
223 ELECTROLYTE IMBALANCE 215 0.0185
224 METASTASES TO MENINGES 42 0.0185
225 METASTATIC NEOPLASM 78 0.0181
226 BREAST CANCER METASTATIC 194 0.0180
227 SEPTIC SHOCK 786 0.0180
228 PULMONARY TOXICITY 127 0.0179
229 LICHENOID KERATOSIS 41 0.0179
230 NEPHROTIC SYNDROME 123 0.0179
231 PSEUDOMEMBRANOUS COLITIS 40 0.0179
232 HEPATIC MASS 34 0.0176
233 HYPOVOLAEMIA 103 0.0176
234 SPLENOMEGALY 206 0.0176
235 JAUNDICE CHOLESTATIC 62 0.0175
236 VENOUS THROMBOSIS LIMB 36 0.0174
237 DUODENAL ULCER 123 0.0174
238 MULTIPLE-DRUG RESISTANCE 54 0.0174
239 HYPERTHERMIA 131 0.0171
240 PERFORMANCE STATUS DECREASED 80 0.0171
241 THROMBOTIC THROMBOCYTOPENIC PURPURA 60 0.0170
242 CAPILLARY LEAK SYNDROME 35 0.0169
243 ELECTROCARDIOGRAM T WAVE INVERSION 37 0.0167
244 HYDRONEPHROSIS 124 0.0165
245 CLOSTRIDIAL INFECTION 56 0.0165
246 ANAPHYLACTOID REACTION 68 0.0165
247 BLOOD CREATINE INCREASED 73 0.0165
248 DRUG TOXICITY 224 0.0164
249 ANAL HAEMORRHAGE 46 0.0164
250 METASTASES TO SPINE 55 0.0163
251 IMMUNE THROMBOCYTOPENIC PURPURA 46 0.0163
252 SQUAMOUS CELL CARCINOMA OF SKIN 98 0.0162
253 LUNG CONSOLIDATION 45 0.0161
254 HAEMOLYTIC ANAEMIA 144 0.0161
255 COMPUTERISED TOMOGRAM ABNORMAL 36 0.0159
256 MYOCARDIAL ISCHAEMIA 179 0.0157
257 MYOCARDITIS 180 0.0157
258 THROMBOPHLEBITIS 55 0.0157
259 PERIPHERAL ISCHAEMIA 64 0.0157
260 KLEBSIELLA INFECTION 79 0.0156
261 BLOOD CHLORIDE DECREASED 40 0.0155
262 GUILLAIN-BARRE SYNDROME 75 0.0155
263 INVASIVE DUCTAL BREAST CARCINOMA 42 0.0154
264 FAILURE TO THRIVE 80 0.0154
265 CARDIAC FAILURE ACUTE 102 0.0153
266 OESOPHAGEAL CANDIDIASIS 61 0.0153
267 NECROSIS 85 0.0153
268 DEAFNESS NEUROSENSORY 50 0.0152
269 RED CELL DISTRIBUTION WIDTH INCREASED 63 0.0151
270 PNEUMONITIS 412 0.0151
271 HYPOCALCAEMIA 284 0.0150
272 METABOLIC ENCEPHALOPATHY 45 0.0150
273 PULMONARY EMBOLISM 1421 0.0149
274 GASTROINTESTINAL OBSTRUCTION 36 0.0149
275 HYPERPYREXIA 63 0.0149
276 COLON CANCER 221 0.0148
277 DEVICE RELATED INFECTION 227 0.0147
278 SKIN REACTION 207 0.0147
279 VENTRICULAR FIBRILLATION 163 0.0147
280 COLITIS ISCHAEMIC 99 0.0147
281 TOXIC ENCEPHALOPATHY 74 0.0146
282 PANCYTOPENIA 813 0.0145
283 INTESTINAL OBSTRUCTION 546 0.0145
284 SUDDEN DEATH 153 0.0144
285 COLITIS 546 0.0144
286 CARDIOGENIC SHOCK 203 0.0141
287 COLITIS MICROSCOPIC 67 0.0141
288 ANOREXIA 182 0.0141
289 CATHETER SITE INFECTION 53 0.0140
290 ACUTE RESPIRATORY DISTRESS SYNDROME 247 0.0140
291 HEPATIC CYTOLYSIS 177 0.0139
292 METASTASES TO CENTRAL NERVOUS SYSTEM 178 0.0138
293 ANAEMIA 2623 0.0137
294 SUSPECTED OFF LABEL USE 62 0.0137
295 DEVICE INFUSION ISSUE 34 0.0137
296 GRANULOCYTOPENIA 78 0.0137
297 MALNUTRITION 153 0.0137
298 LUNG OPACITY 36 0.0136
299 PERITONITIS 280 0.0135
300 LARYNGEAL OEDEMA 83 0.0135
301 FISTULA 151 0.0134
302 DERMATOMYOSITIS 34 0.0134
303 HEPATIC FIBROSIS 46 0.0134
304 LEUKOCYTOSIS 242 0.0134
305 HEPATITIS B 80 0.0133
306 OESOPHAGEAL ULCER 51 0.0133
307 BACTERAEMIA 157 0.0132
308 SHOCK HAEMORRHAGIC 107 0.0131
309 DEHYDRATION 1741 0.0130
310 HYPERTENSIVE CRISIS 143 0.0128
311 ISCHAEMIA 59 0.0128
312 PIGMENTATION DISORDER 79 0.0128
313 PULMONARY FIBROSIS 245 0.0128
314 SEPSIS 1412 0.0126
315 CHOLESTASIS 243 0.0126
316 TROPONIN INCREASED 96 0.0126
317 FAECALOMA 69 0.0126
318 HYPOPHOSPHATAEMIA 93 0.0126
319 TUMOUR MARKER INCREASED 60 0.0125
320 GENERAL PHYSICAL HEALTH DETERIORATION 1443 0.0125
321 CEREBRAL ISCHAEMIA 64 0.0124
322 CYTOPENIA 151 0.0123
323 ENCEPHALOPATHY 301 0.0122
324 HEPATIC ENCEPHALOPATHY 114 0.0122
325 THROMBOTIC MICROANGIOPATHY 119 0.0122
326 SCAB 139 0.0122
327 PAPILLOEDEMA 55 0.0122
328 AGRANULOCYTOSIS 226 0.0121
329 BLOOD LACTIC ACID INCREASED 64 0.0121
330 HYPOPHAGIA 310 0.0121
331 BLOOD ALKALINE PHOSPHATASE INCREASED 301 0.0121
332 PHLEBITIS 62 0.0121
333 TONGUE OEDEMA 46 0.0120
334 HYPERNATRAEMIA 60 0.0120
335 HEPATIC FAILURE 363 0.0120
336 DEEP VEIN THROMBOSIS 780 0.0120
337 CHOLECYSTITIS ACUTE 68 0.0120
338 ACUTE PULMONARY OEDEMA 67 0.0119
339 DUODENAL ULCER HAEMORRHAGE 34 0.0119
340 ABDOMINAL TENDERNESS 59 0.0119
341 BLOOD CREATININE DECREASED 37 0.0118
342 HYPERTRIGLYCERIDAEMIA 69 0.0118
343 NAIL DISORDER 103 0.0118
344 PROTEIN TOTAL DECREASED 44 0.0117
345 ANAL FISTULA 62 0.0116
346 WHITE BLOOD CELL COUNT ABNORMAL 74 0.0116
347 DIARRHOEA HAEMORRHAGIC 108 0.0115
348 SUPRAVENTRICULAR EXTRASYSTOLES 39 0.0115
349 TOXIC SKIN ERUPTION 116 0.0115
350 DUODENITIS 35 0.0114
351 MYELODYSPLASTIC SYNDROME 165 0.0114
352 DERMATITIS 239 0.0114
353 SUPRAVENTRICULAR TACHYCARDIA 109 0.0114
354 LEFT VENTRICULAR FAILURE 39 0.0113
355 LYMPHOPENIA 160 0.0113
356 MULTI-ORGAN FAILURE 195 0.0113
357 VASCULAR DEVICE INFECTION 51 0.0112
358 DERMATITIS EXFOLIATIVE GENERALISED 39 0.0112
359 HAIR DISORDER 92 0.0112
360 ORAL CANDIDIASIS 147 0.0112
361 OLIGURIA 69 0.0111
362 TYPE I HYPERSENSITIVITY 39 0.0111
363 INTRACARDIAC THROMBUS 34 0.0111
364 DIARRHOEA 7146 0.0111
365 BLOOD PHOSPHORUS DECREASED 40 0.0109
366 LUNG INFILTRATION 96 0.0109
367 PNEUMOCYSTIS JIROVECII PNEUMONIA 109 0.0108
368 HYPONATRAEMIA 610 0.0108
369 RECURRENT CANCER 44 0.0108
370 CARDIAC DYSFUNCTION 40 0.0107
371 BACTERIAL SEPSIS 35 0.0107
372 PLEURAL EFFUSION 653 0.0107
373 CANDIDIASIS 43 0.0107
374 ANAL FISSURE 57 0.0106
375 WHITE BLOOD CELL COUNT DECREASED 1150 0.0106
376 STAPHYLOCOCCAL BACTERAEMIA 46 0.0106
377 PULMONARY ALVEOLAR HAEMORRHAGE 59 0.0105
378 CONJUNCTIVITIS 195 0.0105
379 AUTOIMMUNE HAEMOLYTIC ANAEMIA 36 0.0105
380 HEPATOTOXICITY 232 0.0104
381 NEPHROPATHY TOXIC 116 0.0103
382 PURULENT DISCHARGE 44 0.0103
383 BLOOD BILIRUBIN INCREASED 278 0.0103
384 TRISMUS 53 0.0103
385 BLOOD LACTATE DEHYDROGENASE INCREASED 161 0.0102
386 PULSE ABSENT 48 0.0101
387 ACUTE MYOCARDIAL INFARCTION 296 0.0100
388 BLOOD MAGNESIUM DECREASED 86 0.0100
389 CHRONIC MYELOID LEUKAEMIA 46 0.0100
390 BRONCHOPNEUMONIA 34 0.0099
391 STAPHYLOCOCCAL SEPSIS 49 0.0099
392 PNEUMOTHORAX 157 0.0099
393 RASH MACULO-PAPULAR 220 0.0099
394 LUNG NEOPLASM 42 0.0098
395 SKIN NECROSIS 51 0.0098
396 BLEPHARITIS 39 0.0097
397 ACIDOSIS 74 0.0097
398 AORTIC DISSECTION 40 0.0097
399 CORONARY ARTERY STENOSIS 48 0.0095
400 HEPATIC FUNCTION ABNORMAL 355 0.0095
401 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 97 0.0094
402 PNEUMONIA ASPIRATION 236 0.0094
403 ATELECTASIS 90 0.0093
404 ISCHAEMIC STROKE 166 0.0093
405 THROMBOCYTOSIS 34 0.0093
406 FOLLICULITIS 97 0.0092
407 HAEMOLYSIS 71 0.0092
408 MOUTH ULCERATION 193 0.0092
409 APHTHOUS ULCER 71 0.0091
410 CIRCULATORY COLLAPSE 155 0.0091
411 PLATELET COUNT DECREASED 970 0.0091
412 SHOCK 209 0.0091
413 DECREASED APPETITE 2109 0.0091
414 BLOOD UREA INCREASED 152 0.0091
415 RESPIRATORY FAILURE 658 0.0090
416 PYREXIA 3120 0.0090
417 SKIN FISSURES 176 0.0090
418 SPINAL CORD COMPRESSION 35 0.0090
419 ELECTROCARDIOGRAM ABNORMAL 70 0.0089
420 TEMPERATURE INTOLERANCE 92 0.0089
421 ORAL PAIN 199 0.0089
422 SINUS TACHYCARDIA 126 0.0089
423 SARCOIDOSIS 42 0.0088
424 RENAL FAILURE ACUTE 374 0.0088
425 BLOOD CREATININE INCREASED 575 0.0088
426 HEPATITIS CHOLESTATIC 53 0.0088
427 RALES 51 0.0088
428 RENAL TUBULAR NECROSIS 86 0.0088
429 ANGIOPATHY 49 0.0087
430 GAMMA-GLUTAMYLTRANSFERASE INCREASED 193 0.0087
431 PURPURA 77 0.0087
432 VOMITING 4075 0.0087
433 RESPIRATORY DISTRESS 239 0.0087
434 JAUNDICE 233 0.0087
435 TACHYPNOEA 117 0.0086
436 MYOSITIS 77 0.0086
437 HYPERURICAEMIA 35 0.0085
438 DIVERTICULUM INTESTINAL 37 0.0085
439 NEUTROPHILIA 48 0.0084
440 EPISTAXIS 627 0.0084
441 HAEMATOCRIT DECREASED 166 0.0084
442 ASPARTATE AMINOTRANSFERASE INCREASED 444 0.0083
443 RECTAL HAEMORRHAGE 357 0.0083
444 ALTERED STATE OF CONSCIOUSNESS 180 0.0083
445 ABDOMINAL PAIN 1932 0.0083
446 DERMATITIS BULLOUS 60 0.0083
447 MADAROSIS 96 0.0083
448 MELAENA 182 0.0083
449 VENTRICULAR TACHYCARDIA 136 0.0082
450 CEREBRAL INFARCTION 201 0.0082
451 ACUTE RESPIRATORY FAILURE 158 0.0082
452 CLOSTRIDIUM DIFFICILE COLITIS 87 0.0082
453 ENDOCARDITIS 42 0.0082
454 TRANSAMINASES INCREASED 181 0.0081
455 CHEILITIS 44 0.0081
456 DYSARTHRIA 306 0.0081
457 ACUTE KIDNEY INJURY 1236 0.0081
458 SKIN DISORDER 269 0.0081
459 CHOLECYSTITIS 96 0.0081
460 SKIN LESION 221 0.0080
461 PETIT MAL EPILEPSY 41 0.0080
462 PROTHROMBIN TIME PROLONGED 48 0.0080
463 BUNDLE BRANCH BLOCK LEFT 34 0.0080
464 HYPERGLYCAEMIA 291 0.0080
465 LOWER GASTROINTESTINAL HAEMORRHAGE 59 0.0080
466 HAEMATEMESIS 202 0.0080
467 BLOOD SODIUM DECREASED 150 0.0079
468 ANGINA PECTORIS 227 0.0079
469 CHILLS 927 0.0079
470 HEPATIC STEATOSIS 147 0.0079
471 INFUSION RELATED REACTION 521 0.0079
472 GASTROENTERITIS 114 0.0078
473 ALANINE AMINOTRANSFERASE INCREASED 479 0.0078
474 HAIR COLOUR CHANGES 97 0.0078
475 PSYCHOLOGICAL TRAUMA 67 0.0078
476 SQUAMOUS CELL CARCINOMA 73 0.0077
477 C-REACTIVE PROTEIN INCREASED 282 0.0077
478 SKIN HYPERPIGMENTATION 66 0.0077
479 ANURIA 66 0.0077
480 BODY TEMPERATURE INCREASED 156 0.0076
481 PANCREATITIS ACUTE 171 0.0076
482 ANAL ABSCESS 41 0.0076
483 ONYCHOCLASIS 52 0.0075
484 HAEMOGLOBIN DECREASED 773 0.0075
485 HYPOXIA 264 0.0075
486 HAIR TEXTURE ABNORMAL 98 0.0073
487 WOUND INFECTION 80 0.0073
488 ERYTHEMA MULTIFORME 68 0.0073
489 GASTROINTESTINAL INFLAMMATION 57 0.0073
490 BRONCHOSPASM 102 0.0071
491 TACHYCARDIA 635 0.0071
492 NEUTROPHIL COUNT INCREASED 73 0.0071
493 RENAL IMPAIRMENT 598 0.0071
494 CARDIAC FAILURE 566 0.0070
495 REFUSAL OF TREATMENT BY PATIENT 46 0.0070
496 FLUID INTAKE REDUCED 35 0.0070
497 ASTHENIA 2619 0.0070
498 HAEMORRHOIDAL HAEMORRHAGE 34 0.0070
499 ABSCESS 111 0.0070
500 DYSPHAGIA 660 0.0069
501 DRUG-INDUCED LIVER INJURY 218 0.0069
502 PYELONEPHRITIS 60 0.0069
503 MULTIPLE ORGAN DYSFUNCTION SYNDROME 196 0.0069
504 BLOOD POTASSIUM DECREASED 208 0.0069
505 PULMONARY MASS 103 0.0069
506 ULCER 110 0.0069
507 ANAPHYLACTIC SHOCK 178 0.0069
508 LYMPHOCYTE COUNT DECREASED 122 0.0069
509 COAGULOPATHY 115 0.0069
510 PATHOLOGICAL FRACTURE 35 0.0069
511 MITRAL VALVE INCOMPETENCE 78 0.0069
512 DRUG RESISTANCE 177 0.0069
513 HAEMOGLOBIN ABNORMAL 44 0.0068
514 GASTRIC ULCER 130 0.0068
515 FEMORAL NECK FRACTURE 35 0.0068
516 PERICARDIAL EFFUSION 157 0.0068
517 HEPATOCELLULAR INJURY 96 0.0068
518 DISEASE RECURRENCE 321 0.0067
519 GASTROINTESTINAL MOTILITY DISORDER 36 0.0067
520 OSTEONECROSIS OF JAW 166 0.0067
521 BREAST MASS 45 0.0067
522 ARTERIOSCLEROSIS 63 0.0067
523 PARAESTHESIA 1043 0.0066
524 UROSEPSIS 61 0.0066
525 NO THERAPEUTIC RESPONSE 80 0.0066
526 TOXIC EPIDERMAL NECROLYSIS 99 0.0065
527 SINUS BRADYCARDIA 63 0.0065
528 NAUSEA 5127 0.0065
529 HERPES SIMPLEX 42 0.0065
530 ESCHERICHIA INFECTION 53 0.0064
531 VASCULITIS 75 0.0064
532 ATRIAL FIBRILLATION 626 0.0064
533 PNEUMONIA BACTERIAL 59 0.0064
534 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 53 0.0064
535 ORAL DISORDER 47 0.0064
536 LIPASE INCREASED 49 0.0064
537 GENERALISED OEDEMA 79 0.0064
538 METABOLIC DISORDER 37 0.0064
539 FLANK PAIN 59 0.0063
540 PARAESTHESIA ORAL 90 0.0062
541 BLINDNESS TRANSIENT 46 0.0062
542 WHITE BLOOD CELL COUNT INCREASED 237 0.0062
543 CYANOSIS 97 0.0062
544 HYPOTENSION 1231 0.0061
545 BLOOD CALCIUM DECREASED 69 0.0061
546 LYMPHADENOPATHY 216 0.0061
547 ORTHOSTATIC HYPOTENSION 106 0.0061
548 DRUG EXPOSURE DURING PREGNANCY 207 0.0061
549 HAEMATURIA 208 0.0061
550 GINGIVAL BLEEDING 82 0.0060
551 STAPHYLOCOCCAL INFECTION 198 0.0060
552 HYPERCALCAEMIA 74 0.0060
553 POST PROCEDURAL COMPLICATION 115 0.0060
554 LIVER INJURY 147 0.0060
555 METABOLIC ACIDOSIS 191 0.0060
556 PAPULE 42 0.0060
557 PLATELET COUNT ABNORMAL 36 0.0059
558 PETECHIAE 62 0.0059
559 FACIAL PAIN 53 0.0059
560 CANDIDA INFECTION 100 0.0059
561 CARDIO-RESPIRATORY ARREST 247 0.0059
562 BASAL CELL CARCINOMA 92 0.0059
563 RENAL FAILURE 783 0.0059
564 ARTERIOSCLEROSIS CORONARY ARTERY 39 0.0059
565 HYPERKALAEMIA 206 0.0059
566 HEPATITIS 149 0.0058
567 HYPERTENSION 1228 0.0058
568 SKIN INFECTION 65 0.0058
569 INFUSION SITE EXTRAVASATION 36 0.0058
570 VENTRICULAR EXTRASYSTOLES 60 0.0058
571 TENDERNESS 60 0.0058
572 PALLOR 156 0.0057
573 BACTERIAL INFECTION 106 0.0057
574 STATUS EPILEPTICUS 64 0.0057
575 TONGUE DISORDER 41 0.0057
576 ASPIRATION 62 0.0057
577 APHASIA 170 0.0056
578 FOETAL GROWTH RESTRICTION 34 0.0056
579 IMPAIRED QUALITY OF LIFE 80 0.0056
580 GRAND MAL CONVULSION 51 0.0055
581 CYTOKINE RELEASE SYNDROME 110 0.0055
582 FACE OEDEMA 92 0.0054
583 ADRENAL INSUFFICIENCY 66 0.0054
584 RENAL CYST 43 0.0054
585 TOXICITY TO VARIOUS AGENTS 912 0.0054
586 ENCEPHALITIS 37 0.0053
587 ANAL INCONTINENCE 48 0.0053
588 POSTOPERATIVE WOUND INFECTION 36 0.0053
589 SUBARACHNOID HAEMORRHAGE 54 0.0053
590 SALIVARY HYPERSECRETION 53 0.0053
591 HEMIPLEGIA 44 0.0053
592 CARDIAC ARREST 433 0.0052
593 PERIPHERAL COLDNESS 72 0.0052
594 UPPER GASTROINTESTINAL HAEMORRHAGE 88 0.0052
595 APPLICATION SITE ERYTHEMA 137 0.0052
596 SKIN ULCER 135 0.0052
597 CHEST PAIN 956 0.0052
598 TRICUSPID VALVE INCOMPETENCE 41 0.0052
599 ATRIAL FLUTTER 41 0.0051
600 HYPOTHYROIDISM 164 0.0051
601 ALOPECIA 1004 0.0051
602 GASTROINTESTINAL HAEMORRHAGE 427 0.0051
603 HEPATOMEGALY 50 0.0051
604 ANAPHYLACTIC REACTION 281 0.0051
605 APPLICATION SITE PAIN 112 0.0051
606 HEMIPARESIS 86 0.0051
607 OSTEONECROSIS 166 0.0050
608 GASTRIC HAEMORRHAGE 58 0.0050
609 INFECTION 723 0.0050
610 DEPRESSED LEVEL OF CONSCIOUSNESS 197 0.0050
611 GASTRITIS 131 0.0050
612 ATAXIA 59 0.0050
613 ERYTHEMA 1017 0.0049
614 PHARYNGITIS 61 0.0049
615 MOUTH HAEMORRHAGE 36 0.0049
616 TOOTH EXTRACTION 61 0.0049
617 LUNG DISORDER 240 0.0049
618 RED BLOOD CELL COUNT DECREASED 140 0.0049
619 HAEMODIALYSIS 41 0.0049
620 DRUG ERUPTION 86 0.0048
621 LIVER DISORDER 215 0.0048
622 SENSORY LOSS 39 0.0048
623 IMPAIRED HEALING 159 0.0048
624 HAEMATOCHEZIA 267 0.0048
625 ARRHYTHMIA 228 0.0048
626 MOTOR DYSFUNCTION 49 0.0048
627 DYSPNOEA EXERTIONAL 181 0.0048
628 SYNCOPE 479 0.0048
629 CONSTIPATION 1044 0.0048
630 ABDOMINAL PAIN LOWER 120 0.0047
631 PERICARDITIS 79 0.0047
632 OXYGEN SATURATION DECREASED 264 0.0047
633 EMPHYSEMA 47 0.0047
634 RESPIRATORY RATE INCREASED 41 0.0046
635 DYSPHONIA 270 0.0046
636 PULMONARY HAEMORRHAGE 36 0.0046
637 AORTIC ANEURYSM 35 0.0046
638 OEDEMA 249 0.0046
639 RHINITIS 37 0.0046
640 TORSADE DE POINTES 36 0.0046
641 URINARY RETENTION 153 0.0046
642 DRUG INTOLERANCE 442 0.0046
643 HAEMORRHOIDS 89 0.0046
644 DEVICE OCCLUSION 64 0.0045
645 GINGIVAL PAIN 36 0.0045
646 THROAT TIGHTNESS 122 0.0045
647 LUNG INFECTION 70 0.0045
648 COLD SWEAT 79 0.0045
649 MENTAL STATUS CHANGES 124 0.0045
650 HAEMODYNAMIC INSTABILITY 34 0.0045
651 URINE OUTPUT DECREASED 39 0.0045
652 OEDEMA PERIPHERAL 541 0.0044
653 PSEUDOMONAS INFECTION 38 0.0044
654 TUBULOINTERSTITIAL NEPHRITIS 83 0.0044
655 INFLAMMATION 228 0.0044
656 LACRIMATION INCREASED 133 0.0044
657 DYSGEUSIA 327 0.0044
658 FATIGUE 3394 0.0044
659 HAEMORRHAGIC STROKE 34 0.0043
660 THROMBOSIS 350 0.0043
661 GASTROINTESTINAL DISORDER 389 0.0043
662 ACUTE HEPATIC FAILURE 59 0.0043
663 LETHARGY 248 0.0043
664 CARDIOMEGALY 53 0.0043
665 IMMUNOSUPPRESSION 38 0.0043
666 PHOTOSENSITIVITY REACTION 71 0.0043
667 HYPERSENSITIVITY 797 0.0043
668 RETINAL DETACHMENT 39 0.0042
669 DYSURIA 156 0.0042
670 OFF LABEL USE 3691 0.0042
671 HAEMORRHAGE 440 0.0042
672 HYPOAESTHESIA ORAL 63 0.0042
673 COMA 197 0.0041
674 SKIN EXFOLIATION 347 0.0041
675 PNEUMONIA 1315 0.0041
676 BONE DISORDER 74 0.0041
677 PULMONARY OEDEMA 181 0.0040
678 DIABETIC KETOACIDOSIS 97 0.0040
679 DISORIENTATION 160 0.0040
680 CLOSTRIDIUM DIFFICILE INFECTION 88 0.0040
681 OSTEOMYELITIS 73 0.0040
682 TRANSIENT ISCHAEMIC ATTACK 136 0.0040
683 CELLULITIS 203 0.0040
684 SPUTUM DISCOLOURED 38 0.0040
685 PRODUCT USE IN UNAPPROVED INDICATION 991 0.0040
686 TASTE DISORDER 81 0.0040
687 COLORECTAL CANCER 190 0.0040
688 APPENDICITIS 37 0.0040
689 HYPOTHERMIA 40 0.0039
690 PULMONARY HYPERTENSION 82 0.0039
691 WEIGHT DECREASED 1097 0.0039
692 UNRESPONSIVE TO STIMULI 101 0.0039
693 SPINAL OSTEOARTHRITIS 34 0.0039
694 NEURALGIA 94 0.0039
695 POST PROCEDURAL HAEMORRHAGE 45 0.0039
696 IRON DEFICIENCY ANAEMIA 35 0.0038
697 HAEMOPTYSIS 105 0.0038
698 INTERNATIONAL NORMALISED RATIO INCREASED 107 0.0037
699 DELIRIUM 129 0.0037
700 SKIN CANCER 80 0.0037
701 LACTIC ACIDOSIS 120 0.0037
702 RASH 1611 0.0037
703 DYSPNOEA 2089 0.0037
704 STEVENS-JOHNSON SYNDROME 82 0.0037
705 EATING DISORDER 78 0.0037
706 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 255 0.0036
707 SENSORY DISTURBANCE 57 0.0035
708 GASTROINTESTINAL PAIN 39 0.0035
709 TRANSFUSION 37 0.0035
710 IMMUNODEFICIENCY 52 0.0035
711 DEAFNESS 91 0.0035
712 HIP ARTHROPLASTY 53 0.0035
713 BODY TEMPERATURE DECREASED 34 0.0035
714 HYPERTHYROIDISM 50 0.0035
715 PULMONARY ARTERIAL HYPERTENSION 50 0.0034
716 COGNITIVE DISORDER 160 0.0034
717 OBSTRUCTIVE AIRWAYS DISORDER 38 0.0034
718 NEOPLASM 39 0.0034
719 DIVERTICULITIS 94 0.0034
720 GENERALISED TONIC-CLONIC SEIZURE 56 0.0034
721 URINARY TRACT INFECTION 575 0.0034
722 FEEDING DISORDER 68 0.0033
723 FLUSHING 338 0.0033
724 TREATMENT FAILURE 274 0.0033
725 SPEECH DISORDER 171 0.0033
726 HYPERLIPIDAEMIA 39 0.0033
727 LOSS OF CONSCIOUSNESS 418 0.0033
728 HYPERHIDROSIS 419 0.0032
729 BLOOD PRESSURE DECREASED 216 0.0032
730 IMPAIRED GASTRIC EMPTYING 44 0.0032
731 PLATELET COUNT INCREASED 42 0.0032
732 PANCREATITIS 170 0.0032
733 DRY SKIN 428 0.0032
734 EPILEPSY 98 0.0032
735 CEREBRAL HAEMORRHAGE 113 0.0032
736 MASS 44 0.0031
737 COVID-19 PNEUMONIA 37 0.0031
738 HYPOAESTHESIA 469 0.0031
739 URINARY INCONTINENCE 92 0.0031
740 RASH ERYTHEMATOUS 148 0.0031
741 DENTAL CARIES 34 0.0031
742 ELECTROCARDIOGRAM QT PROLONGED 110 0.0031
743 PRESYNCOPE 74 0.0030
744 HEPATIC CIRRHOSIS 57 0.0030
745 RESPIRATORY TRACT INFECTION 79 0.0030
746 BONE PAIN 177 0.0030
747 DERMATITIS ALLERGIC 38 0.0030
748 FEELING HOT 185 0.0030
749 PAIN IN JAW 85 0.0030
750 BRADYCARDIA 159 0.0030
751 DERMATITIS CONTACT 34 0.0030
752 SWOLLEN TONGUE 93 0.0030
753 CORONARY ARTERY DISEASE 90 0.0030
754 ORAL HERPES 58 0.0030
755 CHEST DISCOMFORT 304 0.0030
756 LIVER FUNCTION TEST ABNORMAL 86 0.0030
757 ABDOMINAL DISTENSION 307 0.0029
758 THERAPY NON-RESPONDER 132 0.0029
759 EAR PAIN 57 0.0029
760 NEOPLASM MALIGNANT 195 0.0029
761 NODULE 38 0.0029
762 CONFUSIONAL STATE 469 0.0029
763 CONDITION AGGRAVATED 882 0.0029
764 PRODUCT PRESCRIBING ISSUE 63 0.0029
765 DIPLOPIA 75 0.0029
766 LIP SWELLING 96 0.0029
767 CONVULSION 164 0.0029
768 ABDOMINAL PAIN UPPER 590 0.0029
769 BRAIN OEDEMA 36 0.0028
770 SKIN HAEMORRHAGE 42 0.0028
771 PULMONARY CONGESTION 37 0.0028
772 BACK PAIN 648 0.0028
773 FEELING COLD 77 0.0028
774 MALAISE 1210 0.0028
775 DYSPEPSIA 269 0.0027
776 PHARYNGEAL OEDEMA 42 0.0027
777 RASH PAPULAR 61 0.0027
778 RETCHING 58 0.0027
779 ORAL DISCOMFORT 37 0.0027
780 RASH MACULAR 93 0.0027
781 CARDIAC FAILURE CONGESTIVE 213 0.0026
782 BLISTER 148 0.0026
783 MUSCULAR WEAKNESS 299 0.0026
784 BRAIN FOG 41 0.0026
785 DIALYSIS 37 0.0026
786 PREMATURE BABY 78 0.0026
787 DRUG INTERACTION 411 0.0026
788 IMMUNE SYSTEM DISORDER 34 0.0026
789 HEART RATE IRREGULAR 58 0.0026
790 PAIN OF SKIN 69 0.0026
791 MUSCULOSKELETAL PAIN 133 0.0025
792 CHOLELITHIASIS 83 0.0025
793 DRY MOUTH 205 0.0025
794 MUSCULOSKELETAL CHEST PAIN 39 0.0025
795 MUSCLE TWITCHING 58 0.0025
796 SCAR 43 0.0025
797 AMENORRHOEA 44 0.0025
798 MYOCARDIAL INFARCTION 437 0.0025
799 BLOOD TEST ABNORMAL 35 0.0025
800 HEPATIC ENZYME INCREASED 169 0.0025
801 BLOOD POTASSIUM INCREASED 40 0.0025
802 HERPES ZOSTER 140 0.0024
803 CHROMATURIA 55 0.0024
804 SWELLING FACE 157 0.0024
805 OROPHARYNGEAL PAIN 223 0.0024
806 PANCREATIC CARCINOMA 69 0.0024
807 RHINORRHOEA 154 0.0024
808 COUGH 668 0.0024
809 DEATH 2048 0.0024
810 SEIZURE 273 0.0024
811 THERAPEUTIC RESPONSE DECREASED 143 0.0024
812 FAECES DISCOLOURED 51 0.0023
813 BLOOD PRESSURE INCREASED 357 0.0023
814 GASTRIC CANCER 59 0.0023
815 FUNGAL INFECTION 77 0.0023
816 OSTEOPENIA 35 0.0023
817 AGEUSIA 57 0.0023
818 HAEMORRHAGE INTRACRANIAL 34 0.0023
819 COMPLICATION ASSOCIATED WITH DEVICE 33 0.0023
820 NERVOUS SYSTEM DISORDER 70 0.0022
821 HAEMATOMA 58 0.0022
822 DRUG LEVEL INCREASED 37 0.0022
823 FULL BLOOD COUNT DECREASED 45 0.0022
824 HYPOGLYCAEMIA 108 0.0022
825 CYTOMEGALOVIRUS INFECTION 37 0.0022
826 BLOOD CREATINE PHOSPHOKINASE INCREASED 63 0.0022
827 FREQUENT BOWEL MOVEMENTS 59 0.0022
828 SKIN DISCOLOURATION 100 0.0022
829 FLATULENCE 123 0.0022
830 GLOSSODYNIA 48 0.0021
831 LIVER FUNCTION TEST INCREASED 46 0.0021
832 PREMATURE DELIVERY 34 0.0021
833 LOWER RESPIRATORY TRACT INFECTION 97 0.0021
834 ANGIOEDEMA 94 0.0021
835 BREAST CANCER 198 0.0021
836 PRODUCTIVE COUGH 101 0.0021
837 CEREBROVASCULAR ACCIDENT 358 0.0021
838 BURNING SENSATION 147 0.0021
839 APPLICATION SITE PRURITUS 47 0.0021
840 HEART RATE INCREASED 205 0.0021
841 BLOOD URINE PRESENT 39 0.0021
842 PRURITUS 788 0.0020
843 GASTROENTERITIS VIRAL 37 0.0020
844 RESPIRATORY DISORDER 61 0.0020
845 PHOTOPHOBIA 38 0.0020
846 HOT FLUSH 152 0.0020
847 CARDIOVASCULAR DISORDER 51 0.0020
848 FRACTURE 38 0.0020
849 TINNITUS 92 0.0020
850 BLOOD PRESSURE SYSTOLIC INCREASED 39 0.0020
851 PAIN 1226 0.0020
852 POLLAKIURIA 83 0.0020
853 DIZZINESS 992 0.0020
854 UPPER RESPIRATORY TRACT INFECTION 91 0.0020
855 WOUND 55 0.0020
856 RESTLESSNESS 72 0.0020
857 BLINDNESS 80 0.0020
858 INCORRECT PRODUCT ADMINISTRATION DURATION 42 0.0019
859 VERTIGO 118 0.0019
860 RASH PRURITIC 104 0.0019
861 CYSTITIS 61 0.0019
862 RASH GENERALISED 49 0.0019
863 ERUCTATION 36 0.0019
864 THROAT IRRITATION 83 0.0018
865 TOOTH DISORDER 41 0.0018
866 ILL-DEFINED DISORDER 111 0.0018
867 NECK PAIN 102 0.0018
868 INTENTIONAL PRODUCT USE ISSUE 158 0.0018
869 PRODUCT ADMINISTRATION ERROR 36 0.0018
870 SKIN IRRITATION 81 0.0018
871 ACTIVITIES OF DAILY LIVING IMPAIRED 35 0.0018
872 ACNE 133 0.0018
873 VISUAL ACUITY REDUCED 58 0.0017
874 TREMOR 288 0.0017
875 MUSCLE SPASMS 317 0.0017
876 DRUG INEFFECTIVE 2269 0.0017
877 EYE SWELLING 64 0.0017
878 ECZEMA 90 0.0017
879 GAIT DISTURBANCE 320 0.0017
880 GASTROOESOPHAGEAL REFLUX DISEASE 134 0.0017
881 FALL 548 0.0016
882 MYALGIA 278 0.0016
883 SKIN BURNING SENSATION 117 0.0016
884 PALPITATIONS 191 0.0016
885 OSTEOPOROSIS 67 0.0016
886 DIABETES MELLITUS 123 0.0016
887 AGITATION 117 0.0016
888 DISCOMFORT 97 0.0016
889 DYSSTASIA 46 0.0016
890 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 84 0.0015
891 SURGERY 89 0.0015
892 FEMUR FRACTURE 47 0.0015
893 EYE IRRITATION 87 0.0015
894 PRODUCT PRESCRIBING ERROR 36 0.0015
895 CARDIAC DISORDER 141 0.0015
896 CHRONIC KIDNEY DISEASE 114 0.0015
897 OCULAR HYPERAEMIA 71 0.0015
898 ARTHROPATHY 83 0.0015
899 LABORATORY TEST ABNORMAL 44 0.0015
900 MATERNAL EXPOSURE DURING PREGNANCY 132 0.0015
901 BRONCHITIS 109 0.0015
902 SWELLING 137 0.0015
903 COVID-19 256 0.0015
904 VAGINAL HAEMORRHAGE 63 0.0015
905 PRODUCT USE ISSUE 272 0.0014
906 RENAL DISORDER 67 0.0014
907 PERIPHERAL SWELLING 221 0.0014
908 PAIN IN EXTREMITY 421 0.0014
909 EMOTIONAL DISORDER 44 0.0014
910 OESOPHAGEAL CARCINOMA 42 0.0014
911 RESPIRATORY ARREST 39 0.0014
912 LOCALISED INFECTION 34 0.0014
913 INFLUENZA LIKE ILLNESS 115 0.0014
914 HYPOACUSIS 60 0.0014
915 SOMNOLENCE 280 0.0014
916 CONTRAINDICATED PRODUCT ADMINISTERED 42 0.0014
917 BLOOD PRESSURE FLUCTUATION 33 0.0014
918 URTICARIA 230 0.0014
919 DRY EYE 67 0.0013
920 BALANCE DISORDER 116 0.0013
921 ADVERSE EVENT 123 0.0013
922 CATARACT 79 0.0013
923 GAIT INABILITY 44 0.0013
924 FOETAL EXPOSURE DURING PREGNANCY 107 0.0013
925 NEPHROLITHIASIS 60 0.0013
926 SLEEP DISORDER 92 0.0013
927 JOINT STIFFNESS 34 0.0013
928 NIGHT SWEATS 41 0.0013
929 HEADACHE 792 0.0013
930 RHABDOMYOLYSIS 52 0.0012
931 VISUAL IMPAIRMENT 154 0.0012
932 INSOMNIA 330 0.0012
933 DRUG EFFECT INCOMPLETE 45 0.0012
934 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 59 0.0012
935 OSTEOARTHRITIS 52 0.0012
936 HEART RATE DECREASED 43 0.0012
937 VISION BLURRED 168 0.0012
938 ADVERSE DRUG REACTION 108 0.0012
939 THERAPY CESSATION 61 0.0012
940 DEPRESSED MOOD 62 0.0012
941 MEDICATION ERROR 65 0.0012
942 ARTHRALGIA 483 0.0012
943 HIP FRACTURE 37 0.0011
944 TREATMENT NONCOMPLIANCE 62 0.0011
945 DYSKINESIA 45 0.0011
946 ABDOMINAL DISCOMFORT 185 0.0011
947 ACCIDENTAL OVERDOSE 40 0.0011
948 MUSCULOSKELETAL STIFFNESS 95 0.0011
949 ANXIETY 300 0.0011
950 THERAPY INTERRUPTED 75 0.0010
951 DEVICE DISLOCATION 45 0.0010
952 AMNESIA 67 0.0010
953 HALLUCINATION 77 0.0010
954 EXPOSURE DURING PREGNANCY 63 0.0010
955 EYE DISORDER 33 0.0010
956 DISTURBANCE IN ATTENTION 54 0.0010
957 WHEEZING 59 0.0010
958 EYE PAIN 56 0.0010
959 BLOOD GLUCOSE INCREASED 184 0.0010
960 MOBILITY DECREASED 70 0.0010
961 DEPRESSION 220 0.0010
962 CONTUSION 92 0.0010
963 NASAL CONGESTION 56 0.0010
964 NASOPHARYNGITIS 174 0.0009
965 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 163 0.0009
966 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 47 0.0009
967 COLITIS ULCERATIVE 40 0.0009
968 UNEVALUABLE EVENT 67 0.0009
969 ASTHMA 99 0.0009
970 LUNG NEOPLASM MALIGNANT 34 0.0008
971 ARTHRITIS 65 0.0008
972 MEMORY IMPAIRMENT 111 0.0008
973 FEELING ABNORMAL 189 0.0008
974 SINUSITIS 79 0.0008
975 FLUID RETENTION 38 0.0007
976 INFLUENZA 82 0.0007
977 WEIGHT INCREASED 160 0.0007
978 JOINT SWELLING 85 0.0007
979 EMOTIONAL DISTRESS 85 0.0007
980 ILLNESS 72 0.0007
981 IRRITABILITY 42 0.0007
982 OVERDOSE 150 0.0007
983 UNDERDOSE 48 0.0007
984 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 39 0.0005
985 ACCIDENTAL EXPOSURE TO PRODUCT 56 0.0005
986 INJURY 35 0.0005
987 MIGRAINE 40 0.0004
988 NO ADVERSE EVENT 64 0.0004
989 HOSPITALISATION 54 0.0004
990 PSORIASIS 44 0.0003
991 PRODUCT DOSE OMISSION ISSUE 96 0.0003
992 RHEUMATOID ARTHRITIS 36 0.0003
993 INCORRECT DOSE ADMINISTERED 65 0.0003
994 PRODUCT QUALITY ISSUE 36 0.0003
995 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 50 0.0002
996 INJECTION SITE PAIN 46 0.0001